combretastatin has been researched along with Thyroid Cancer, Anaplastic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deshpande, HA; Roman, S; Sosa, JA | 1 |
1 review(s) available for combretastatin and Thyroid Cancer, Anaplastic
| Article | Year |
|---|---|
New targeted therapies and other advances in the management of anaplastic thyroid cancer.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bibenzyls; Clinical Trials as Topic; Drug Therapy, Combination; Histone Deacetylase Inhibitors; Humans; Molecular Targeted Therapy; Protein Kinase Inhibitors; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms | 2013 |